Bladder Cancer Coverage from Every Angle
Advertisement
Advertisement

Aristotelis Bamias, MD, PhD, on Urothelial Carcinoma: Atezolizumab and Platinum-Based Chemotherapy

Posted: Friday, October 30, 2020

Aristotelis Bamias, MD, PhD, of the University of Athens, discusses patient-reported outcomes from the IMvigor 130 study, which showed atezolizumab plus platinum-based chemotherapy (gemcitabine with either cisplatin or carboplatin) may be an important new treatment option for patients with untreated metastatic urothelial carcinoma.



By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.